Risk- and response-based classification of childhood B-precursor acute lymphoblastic leukemia: a combined analysis of prognostic markers from the Pediatric Oncology Group (POG) and Children's Cancer Group (CCG)Kirk R. Schultz, Bruce M. Camitta, DJ Pullen et al.|Blood|2006Cited by 475
Increasing Incidence of Chronic Graft-versus-Host Disease in Allogeneic Transplantation: A Report from the Center for International Blood and Marrow Transplant ResearchSally Arai, Yoshiko Atsuta, Olle Ringdén et al.|Biology of Blood and Marrow Transplantation|2014Cited by 435
Children’s Oncology Group AALL0434: A Phase III Randomized Clinical Trial Testing Nelarabine in Newly Diagnosed T-Cell Acute Lymphoblastic LeukemiaKimberly P. Dunsmore, Stephen P. Hunger, Stuart S. Winter et al.|Journal of Clinical Oncology|2020Cited by 254
Dasatinib Plus Intensive Chemotherapy in Children, Adolescents, and Young Adults With Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia: Results of Children’s Oncology Group Trial AALL0622William B. Slayton, Stephen P. Hunger, Kirk R. Schultz et al.|Journal of Clinical Oncology|2018Cited by 249
Phase II Trial of Costimulation Blockade With Abatacept for Prevention of Acute GVHDBenjamin Watkins, Leslie S. Kean, Muna Qayed et al.|Journal of Clinical Oncology|2021Cited by 247